The global biologics and biosimilars industry is witnessing substantial expansion as healthcare systems increasingly adopt advanced therapeutic solutions for chronic and life threatening diseases. Rising prevalence of cancer, autoimmune disorders, infectious diseases, and blood disorders has accelerated the demand for innovative biologic therapies and cost effective biosimilar alternatives...